Qube Research & Technologies Ltd

Holdings History for Tarsus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TARS)

Symbol: TARS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	-0.01%	$32,853,613	401,241	-121,035	-23%	$81.88	Q4 2025
30 Sep 2025	0.04%	+0.01%	$31,038,863	522,276	+62,840	+14%	$59.43	Q3 2025
30 Jun 2025	0.03%	+0.01%	$18,611,752	459,436	+212,592	+86%	$40.51	Q2 2025
31 Mar 2025	0.02%	+0.01%	$12,680,376	246,844	+148,848	+100%	$51.37	Q1 2025
31 Dec 2024	0.01%	+0%	$5,426,039	97,996	+33,313	+52%	$55.37	Q4 2024
30 Sep 2024	0%	-0.01%	$2,127,424	64,683	-162,196	-71%	$32.89	Q3 2024
30 Jun 2024	0.01%	+0.01%	$6,166,571	226,879	+193,516	+580%	$27.18	Q2 2024
31 Mar 2024	0%	+0%	$1,212,745	33,363	+27,535	+472%	$36.35	Q1 2024
31 Dec 2023	0%	+0%	$118,017	5,828	+5,828	NEW	$20.25	Q4 2023
30 Jun 2023		-0%	$0	0	-10,352	-100%	$63.25	Q2 2023
31 Mar 2023	0%	+0%	$130,125	10,352	+10,352	NEW	$12.57	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.